2-Fluoro-1,3,5-trimethylbenzene | CAS:392-69-8

We serve 2-Fluoro-1,3,5-trimethylbenzene CAS:392-69-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Fluoro-1,3,5-trimethylbenzene

Chemical Name:2-Fluoro-1,3,5-trimethylbenzene
CAS.NO:392-69-8
Synonyms:2-Fluoro-1,3,5-trimethylbenzene
Fluoromesitylene
2,4,6-trimethylfluorobenzene
1-Fluoro-2,4,6-trimethylbenzene
 
Physical and Chemical Properties:
Density 1.0±0.1 g/cm3
Boiling Point 169.7±9.0 °C at 760 mmHg
Melting Point -36.7℃
Molecular Formula C9H11F
Molecular Weight 138.182
Flash Point 47.6±6.2 °C
Vapour Pressure 2.0±0.3 mmHg at 25°C
Index of Refraction 1.483
 
Specification:
Appearance:Light yellow transparent liquid
Assay:≥98.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.



Contact us for information like 2-Fluoro-1,3,5-trimethylbenzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Fluoro-2,4,6-trimethylbenzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-Fluoro-2,4,6-trimethylbenzene Use and application,2-Fluoro-1,3,5-trimethylbenzene technical grade,usp/ep/jp grade.


Related News: They should also not use public transport for a fortnight after returning to Britain.2-Hydroxyethylurea manufacturer But now, the metropolis of 11 million in Hubei province has become the face of a deadly coronavirus outbreak — a stigma the people of Wuhan increasingly find themselves unable to shake off.4-Chloro-3-nitroanisole supplier If the drug is in a syrup form, then the excipient is the liquid that has been used to make it as such.4-(Methylsulfonyl)phenylboronic Acid vendor Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country.The upstream industry for the R & D, production and sales of pharmaceutical intermediates is the basic chemical raw material industry, and the downstream industry is the chemical bulk drug and chemical pharmaceutical preparation industry.